Stroke center procurement teams face a recurring question: which neurovascular device supplier can reliably support a program that treats time-sensitive, high-acuity cases around the clock. The answer rarely comes down to a single device or a single price point. Instead, experienced procurement and clinical engineering teams tend to evaluate suppliers across several dimensions — portfolio breadth, regulatory standing, manufacturing quality, and the practical support structure around training and traceability. This guide walks through those criteria using INVAMED's MicroCATH Neurovascular Catheter Family as a reference example, and outlines the kinds of questions a stroke program should be asking before finalizing a supplier relationship.
Why Does Portfolio Breadth Matter for a Stroke Program?
A stroke or neurointerventional program handles a range of case types — large vessel occlusion thrombectomy, aneurysm coiling, and liquid embolic delivery among them — and each case type often calls for different microcatheter configurations suited to distinct anatomical targets. A neurovascular device supplier offering a broad, coherent neuro portfolio can reduce the operational complexity of managing multiple vendor relationships and can make it easier to standardize training across the interventional team. INVAMED's MicroCATH Neurovascular Catheter Family is described by the manufacturer as a comprehensive microcatheter lineup intended to support coiling, liquid embolic infusion, and distal neurovascular exploration, with a design intended to enable fine navigation through tortuous cerebral arteries. Programs evaluating portfolio breadth generally look at whether a single supplier's catheter family can reasonably cover their typical procedural mix, while recognizing that some cases may still call for supplemental devices depending on specific anatomy.
What Regulatory Credentials Should Procurement Teams Verify?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
How Should Stroke Center Procurement Weigh Training and Support?
Device training is frequently underweighted in supplier comparisons that focus mainly on unit pricing, yet it has a direct bearing on how confidently a clinical team adopts a new catheter system. Stroke center procurement teams generally benefit from asking prospective suppliers detailed questions about proctoring availability, simulation or bench-training resources, and the responsiveness of clinical support during initial case adoption. A supplier with a broad neuro portfolio, such as a full microcatheter family spanning multiple procedural uses, can also simplify training because staff become familiar with a consistent handling profile and delivery system across device variants rather than learning disparate systems from multiple vendors. Programs should also ask how a supplier handles urgent restocking, since neurointerventional procedures are frequently unscheduled and emergent by nature.
Should a stroke program use a single supplier for its entire neurovascular portfolio?
Not necessarily. Some programs consolidate around a supplier with broad portfolio coverage to simplify training and inventory management, while others maintain relationships with multiple suppliers to ensure device options for varied anatomy. The right approach depends on institutional case volume, procedural mix, and internal procurement criteria.